128 related articles for article (PubMed ID: 33508276)
1. The NRG3/ERBB4 signaling cascade as a novel therapeutic target for canine glioma.
Noguchi S; Inoue M; Ichikawa T; Kurozumi K; Matsumoto Y; Nakamoto Y; Akiyoshi H; Kamishina H
Exp Cell Res; 2021 Mar; 400(2):112504. PubMed ID: 33508276
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic efficiency of pan-ERBB inhibitors for canine glioma.
Noguchi S; Yasumura M
Vet Res Commun; 2023 Dec; 47(4):2207-2213. PubMed ID: 36991174
[TBL] [Abstract][Full Text] [Related]
3. PTPN21 exerts pro-neuronal survival and neuritic elongation via ErbB4/NRG3 signaling.
Plani-Lam JH; Chow TC; Siu KL; Chau WH; Ng MH; Bao S; Ng CT; Sham P; Shum DK; Ingley E; Jin DY; Song YQ
Int J Biochem Cell Biol; 2015 Apr; 61():53-62. PubMed ID: 25681686
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ_0074026 indicates unfavorable prognosis for patients with glioma and facilitates oncogenesis of tumor cells by targeting miR-1304 to modulate ERBB4 expression.
Chen M; Liu X; Xie P; Wang P; Liu M; Zhan Y; Wang H; Feng Y; Li Y
J Cell Physiol; 2020 May; 235(5):4688-4697. PubMed ID: 31643077
[TBL] [Abstract][Full Text] [Related]
5. Association of NRG3 and ERBB4 gene polymorphism with nicotine dependence in Turkish population.
Kara HG; Erdal ME; Yılmaz SG; Şengül C; Şengül CB; Karakülah K
Mol Biol Rep; 2021 Jun; 48(6):5319-5326. PubMed ID: 34247340
[TBL] [Abstract][Full Text] [Related]
6. Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence.
Turner JR; Ray R; Lee B; Everett L; Xiang J; Jepson C; Kaestner KH; Lerman C; Blendy JA
Mol Psychiatry; 2014 Jul; 19(7):801-10. PubMed ID: 23999525
[TBL] [Abstract][Full Text] [Related]
7. Dynamic effects of ventral hippocampal NRG3/ERBB4 signaling on nicotine withdrawal-induced responses.
Fisher ML; Prantzalos ER; O'Donovan B; Anderson TL; Sahoo PK; Twiss JL; Ortinski PI; Turner JR
Neuropharmacology; 2024 Apr; 247():109846. PubMed ID: 38211698
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4.
Zhang D; Sliwkowski MX; Mark M; Frantz G; Akita R; Sun Y; Hillan K; Crowley C; Brush J; Godowski PJ
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9562-7. PubMed ID: 9275162
[TBL] [Abstract][Full Text] [Related]
9. Transcytosis and trans-synaptic retention by postsynaptic ErbB4 underlie axonal accumulation of NRG3.
Ahmad T; Vullhorst D; Chaudhuri R; Guardia CM; Chaudhary N; Karavanova I; Bonifacino JS; Buonanno A
J Cell Biol; 2022 Jul; 221(7):. PubMed ID: 35579602
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin 3 promotes excitatory synapse formation on hippocampal interneurons.
Müller T; Braud S; Jüttner R; Voigt BC; Paulick K; Sheean ME; Klisch C; Gueneykaya D; Rathjen FG; Geiger JR; Poulet JF; Birchmeier C
EMBO J; 2018 Sep; 37(17):. PubMed ID: 30049711
[TBL] [Abstract][Full Text] [Related]
11. Transient overexposure of neuregulin 3 during early postnatal development impacts selective behaviors in adulthood.
Paterson C; Law AJ
PLoS One; 2014; 9(8):e104172. PubMed ID: 25093331
[TBL] [Abstract][Full Text] [Related]
12. Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas.
Fraser AR; Bacci B; le Chevoir MA; Long SN
Vet Pathol; 2016 Nov; 53(6):1131-1137. PubMed ID: 27154542
[TBL] [Abstract][Full Text] [Related]
13. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
14. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral temozolomide in spontaneous canine gliomas: feasibility of a novel therapy using implanted microcylinders.
Hicks J; Platt S; Stewart G; Senneca C; Holmes S; Kent M; Howerth E; Kaplan J; Kaplan E
Vet Med Sci; 2019 Feb; 5(1):5-18. PubMed ID: 30394686
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
Haskins JW; Nguyen DX; Stern DF
Sci Signal; 2014 Dec; 7(355):ra116. PubMed ID: 25492965
[TBL] [Abstract][Full Text] [Related]
18. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin-3 regulates epithelial progenitor cell positioning and specifies mammary phenotype.
Kogata N; Oliemuller E; Wansbury O; Howard BA
Stem Cells Dev; 2014 Nov; 23(22):2758-70. PubMed ID: 24936779
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of circular RNA CEP128 suppresses proliferation and improves cytotoxic efficacy of temozolomide in glioma cells by regulating miR-145-5p.
Hua L; Huang L; Zhang X; Feng H; Shen B
Neuroreport; 2019 Dec; 30(18):1231-1238. PubMed ID: 31599823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
